Looking to the Future: Innovative Approaches to #HIV #Vaccine Development and Immunotherapies

Charles Nicolette - Argos TherapeuticsWe had the pleasure of welcoming Dr Charles Nicolette, the Chief Scientific Officer and R&D Vice President at Argos Therapeutics at the most recent World Vaccine Congress Washington in April to hear about his work on personalised HIV treatment to patient's own virus strain.

Dr Nicolette shared his findings on personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other infectious diseases and how to address the challenges of the unique genetic profile of each patient´s disease and the genetic mutations.

I believe that Dr Nicolette gave us a snapshot of the future of vaccine and medicine development where a lot of work is being done in personalising products for higher efficiency and efficacy.

Download the whole presentation here.

Leave a Reply

Your email address will not be published. Required fields are marked *